FR2267107A1 - - Google Patents

Info

Publication number
FR2267107A1
FR2267107A1 FR7510763A FR7510763A FR2267107A1 FR 2267107 A1 FR2267107 A1 FR 2267107A1 FR 7510763 A FR7510763 A FR 7510763A FR 7510763 A FR7510763 A FR 7510763A FR 2267107 A1 FR2267107 A1 FR 2267107A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7510763A
Other languages
French (fr)
Other versions
FR2267107B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of FR2267107A1 publication Critical patent/FR2267107A1/fr
Application granted granted Critical
Publication of FR2267107B1 publication Critical patent/FR2267107B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7510763A 1974-04-11 1975-04-07 Expired FR2267107B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46025474A 1974-04-11 1974-04-11

Publications (2)

Publication Number Publication Date
FR2267107A1 true FR2267107A1 (ja) 1975-11-07
FR2267107B1 FR2267107B1 (ja) 1978-07-28

Family

ID=23827960

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7510763A Expired FR2267107B1 (ja) 1974-04-11 1975-04-07

Country Status (7)

Country Link
JP (1) JPS535729B2 (ja)
AU (1) AU7776275A (ja)
CA (1) CA1049409A (ja)
DE (2) DE2504615C3 (ja)
DK (1) DK143537C (ja)
FR (1) FR2267107B1 (ja)
GB (1) GB1455552A (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3376957D1 (en) * 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
AU592065B2 (en) * 1984-10-09 1990-01-04 Dow Chemical Company, The Sustained release dosage form based on highly plasticized cellulose ether gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
ES2078256T3 (es) * 1990-04-05 1995-12-16 Knoll Ag Formula farmaceutica para uso topico que contiene diclofenaco sodico.
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
PL2366408T3 (pl) * 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017746B (de) * 1954-02-09 1957-10-17 Upjohn Co Verfahren zur Herstellung frei fliessender, nicht absetzender therapeutisch wirksamer Suspensionen
US3485915A (en) * 1966-04-22 1969-12-23 Revlon Thickened hydroxypropyl cellulose compositions
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DK135267A (ja) * 1971-02-25

Also Published As

Publication number Publication date
DE2515594A1 (de) 1975-10-30
CA1049409A (en) 1979-02-27
JPS535729B2 (ja) 1978-03-01
GB1455552A (en) 1976-11-17
DK147575A (ja) 1975-10-12
DE2504615A1 (de) 1975-10-16
DK143537C (da) 1982-02-01
DK143537B (da) 1981-09-07
FR2267107B1 (ja) 1978-07-28
AU7776275A (en) 1976-08-05
DE2504615B2 (de) 1977-07-14
DE2515594C3 (de) 1982-06-03
JPS50132122A (ja) 1975-10-20
DE2504615C3 (de) 1980-10-02
DE2515594B2 (de) 1978-12-07

Similar Documents

Publication Publication Date Title
FR2265112B1 (ja)
FR2275650B2 (ja)
FR2267107B1 (ja)
FR2282563B1 (ja)
FR2288012B1 (ja)
FR2271067B3 (ja)
AU495920B2 (ja)
AU7099174A (ja)
AU7138274A (ja)
CH594097A5 (ja)
AU481580A (ja)
BG19607A1 (ja)
DD117432A5 (ja)
DD110704A1 (ja)
DD124575A5 (ja)
BG21805A1 (ja)
CH606488A5 (ja)
CH601535A5 (ja)
CH594425A5 (ja)
BG20650A1 (ja)
BG20443A1 (ja)
CH590407A5 (ja)
CH584861A5 (ja)
BG21632A1 (ja)
CH1357474A4 (ja)

Legal Events

Date Code Title Description
ST Notification of lapse